Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-MVD Antibody (R1Y75)

Catalog #:   RHE98601 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: P53602
Overview

Catalog No.

RHE98601

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

Mevalonate pyrophosphate decarboxylase, Diphosphomevalonate decarboxylase, Mevalonate (diphospho)decarboxylase, MPD, MVD, MDDase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P53602

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Y75

Data Image
  • Western blot
    Western blot analysis of MVD expression in K562 cell lysate.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
References

Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies., PMID:40487708

Comparison of Microvessel Density and Growth Factor Levels Between Inner and Outer Prepuce in Distal Hypospadias., PMID:40434280

Marburg virus disease in Rwanda: an observational study of the first 10 days of outbreak response, clinical interventions, and outcomes., PMID:40394565

Emerging Strategies and Progress in the Medical Management of Marburg Virus Disease., PMID:40333077

Correlation of shear wave elastography with histopathological grade, tumor stage, and microvessel density in bladder cancer., PMID:40312900

Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation., PMID:40226614

Macular microvascular and structural changes on optical coherence tomography angiography in atypical optic neuritis., PMID:40115398

CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence., PMID:39906069

Type 2 diabetes patients exhibit delayed but coupled bone remodelling, maintaining cortical porosity comparable to healthy controls: A histomorphometric analysis of trans-iliac bone biopsies., PMID:39884487

Immunohistochemical Expression of VEGF and Microvessel Density (CD 34) in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: Original Research., PMID:39873996

Effects of ranibizumab on microvasculature, oxidative stress and recurrence in primary pterygium surgery., PMID:39832029

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans., PMID:39771978

A surrogate BSL2-compliant infection model recapitulating key aspects of human Marburg virus disease., PMID:39745141

Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer., PMID:39639042

Serological Evidence of Potential Marburg Virus Circulation in Livestock and Dogs in Ghana., PMID:39599470

CardiLect: A combined cross-species lectin histochemistry protocol for the automated analysis of cardiac remodelling., PMID:39535377

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity., PMID:39465249

Anti-VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis., PMID:39462847

Evaluation of Tumor-Associated Macrophages and Micro-Vessel Density in Verrucous Carcinoma and Squamous Cell Carcinoma of the Oral Cavity., PMID:39434951

Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial., PMID:39430462

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study., PMID:39377745

PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model., PMID:39231916

Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial., PMID:39187595

Novel role of CD34+ stromal cells/telocytes in oral submucous fibrosis development and its malignant transformation., PMID:39089508

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer., PMID:39041200

The prognostic significance of CD117-positive mast cells and microvessel density in colorectal cancer., PMID:39029054

Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways., PMID:38898449

Diagnosis of Coccidioidomycosis with the Second-Generation Miravista IgG and IgM Enzyme Immunoassay and the Role of Adding Miravista Coccidioides Antigen Detection to Immunodiagnostic Assays., PMID:38871943

Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis., PMID:38834833

Novel antiviral approaches for Marburg: a promising therapeutics in the pipeline., PMID:38725678

TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression., PMID:38664392

Effect of Poly(ethylene glycol) Configuration on Microbubble Pharmacokinetics., PMID:38600786

Role of CD34-immunopositive Microvascular Density in Juvenile Nasopharyngeal Angiofibroma., PMID:38566736

Immune status and selection of patients for immunotherapy in myeloma: a proposal., PMID:38564776

Assessment of the Effects of Sphingosine Kinase 1/Sphingosine-1-Phosphate on Microangiogenesis at Rat Myofascial Trigger Points Using Contrast-Enhanced Ultrasonography., PMID:38371480

Dermatoscopic Characteristics, Lesional Capillaroscopic Features, and Histopathological Correlation of Small Plaque Parapsoriasis and Mycosis Fungoides., PMID:38364405

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)., PMID:38343800

Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease., PMID:38325990

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome., PMID:38321023

Production and Purification of Filovirus Glycoproteins., PMID:38315357

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146., PMID:38242717

Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus., PMID:38140590

Microvascular Disease Associates with Larger Osteocyte Lacunae in Cortical Bone in Type 2 Diabetes Mellitus., PMID:38025042

Correlation of microvessel density with histopathological parameters of carcinoma breast., PMID:38006344

Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment., PMID:37984124

Immunohistochemical Assessment of Microvessel Density in OSCC: Spatial Heterogeneity of Angiogenesis and Its Impact on Survival., PMID:37893098

PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry., PMID:37564209

Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma., PMID:37323605

A retrospective study on immunohistochemical evaluation of CD34 in the pathogenesis of oral lichen planus., PMID:37234336

IRF7 and IFIT2 in mediating different hemorrhage outcomes for non-small cell lung cancer after bevacizumab treatment., PMID:37197507

Datasheet

Document Download

Anti-MVD Antibody (R1Y75).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-MVD Antibody (R1Y75) [RHE98601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only